Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
European Radiology
Published in: European Radiology 7/2018

Open Access 01-07-2018 | Contrast Media

Post-contrast acute kidney injury – Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors

Recommendations for updated ESUR Contrast Medium Safety Committee guidelines

Authors: Aart J. van der Molen, Peter Reimer, Ilona A. Dekkers, Georg Bongartz, Marie-France Bellin, Michele Bertolotto, Olivier Clement, Gertraud Heinz-Peer, Fulvio Stacul, Judith A. W. Webb, Henrik S. Thomsen

Published in: European Radiology | Issue 7/2018

Login to get access

Abstract

Purpose

The Contrast Media Safety Committee (CMSC) of the European Society of Urogenital Radiology (ESUR) has updated its 2011 guidelines on the prevention of post-contrast acute kidney injury (PC-AKI). The results of the literature review and the recommendations based on it, which were used to prepare the new guidelines, are presented in two papers.

Areas covered in part 1

Topics reviewed include the terminology used, the best way to measure eGFR, the definition of PC-AKI, and the risk factors for PC-AKI, including whether the risk with intravenous and intra-arterial contrast medium differs.

Key Points

• PC-AKI is the preferred term for renal function deterioration after contrast medium.
• PC-AKI has many possible causes.
• The risk of AKI caused by intravascular contrast medium has been overstated.
• Important patient risk factors for PC-AKI are CKD and dehydration.
Literature
1.
Stacul F, van der Molen AJ, Reimer P, Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) et al (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21:2527–2541CrossRefPubMed
2.
Morcos SK, Thomsen HS, Webb JA, Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR) et al (2002) Dialysis and contrast media. Eur Radiol 12:3026–3030PubMed
3.
4.
Gruberg L, Mintz GS, Mehran R et al (2000) The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36:1542–1548CrossRefPubMed
5.
Gupta R, Gurm HS, Bhatt DL et al (2005) Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv 64:442–448CrossRefPubMed
6.
James MT, Samuel SM, Manning MA et al (2013) Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography a systematic review and meta-analysis. Circ Cardiovasc Interv 6:37–43CrossRefPubMed
7.
Kooiman J, Seth M, Nallamothu BK et al (2015) Association between acute kidney injury and in-hospital mortality in patients undergoing percutaneous coronary interventions. Circ Cardiovasc Interv 8:e002212CrossRefPubMed
8.
Mitchell AM, Kline JA, Jones AE et al (2015) Major adverse events one year after acute kidney injury after contrast-enhanced computed tomography. Ann Emerg Med 66:267–274.e4CrossRefPubMed
9.
Rihal CS, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264CrossRefPubMed
10.
Rudnick M, Feldman H (2008) Contrast-induced nephropathy: what are the true clinical consequences? Clin J Am Soc Nephrol 3:263–272CrossRefPubMed
11.
Kooiman J, Pasha SM, Zondag W et al (2012) Meta-analysis: serum creatinine changes following contrast enhanced CT imaging. Eur J Radiol 81:2554–2561CrossRefPubMed
12.
Moos SI, van Vemde DN, Stoker J et al (2013) Contrast induced nephropathy in patients undergoing intravenous (IV) contrast enhanced computed tomography (CECT) and the relationship with risk factors: a meta-analysis. Eur J Radiol 82:e387–e399CrossRefPubMed
13.
14.
15.
Keeley EC (1998) Grines CL (1998) Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases. J Am Coll Cardiol 32:1861–1865CrossRefPubMed
16.
Wichmann JL, Katzberg RW, Litwin SE et al (2015) Contrast-induced nephropathy. Circulation 132:1931–1936CrossRefPubMed
17.
Newhouse JH, Kho D, Rao QA et al (2008) Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 191:376–382CrossRefPubMed
18.
Bruce RJ, Djamali A, Shinki K et al (2009) Background fluctuation of kidney function versus contrast-induced nephrotoxicity. AJR American Journal of Roentgenology 192:711–718CrossRefPubMed
19.
Brouwers M, Kho ME, Browman GP, on behalf of the AGREE Next Steps Consortium et al (2010) AGREE II: Advancing guideline development, reporting and evaluation in healthcare. Can Med Assoc J 182:E839–E842CrossRef
20.
Guyatt GH, Oxman AD, Kunz R et al (2011) GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 64:395–400CrossRefPubMed
21.
22.
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup (2004) Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204–R212CrossRefPubMedPubMedCentral
23.
Levey AS, Eckardt KU, Tsukamoto Y et al (2005) Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67:2089–2100CrossRefPubMed
24.
Mehta RL, Kellum JA, Shah SV et al (2007) Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31CrossRefPubMedPubMedCentral
25.
26.
27.
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2:1–138CrossRef
28.
Morcos SK, Thomsen HS, Webb JA (1999) Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9:1602–1613CrossRefPubMed
29.
Pyxaras SA, Zhang Y, Wolf A, Schmitz T, Naber CK (2015) Effect of varying definitions of contrast-induced acute kidney injury and left ventricular ejection fraction on one-year mortality in patients having transcatheter aortic valve implantation. Am J Cardiol 116:426–430CrossRefPubMed
30.
Slocum NK, Grossman PM, Moscucci M et al (2012) The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Am Heart J 163:829–834CrossRefPubMed
31.
Weisbord SD, Mor MK, Resnick AL, Hartwig KC, Palevsky PM, Fine MJ (2008) Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol 3:1274–1281CrossRefPubMedPubMedCentral
32.
Budano C, Levis M, D'Amico M et al (2011) Impact of contrast-induced acute kidney injury definition on clinical outcomes. Am Heart J 161:963–971CrossRefPubMed
33.
Azzouz M, Rømsing J, Thomsen HS (2014) Fluctuations in eGFR in relation to unenhanced and enhanced MRI and CT outpatients. Eur J Radiol 83:886–892CrossRefPubMed
34.
Thomsen HS, Morcos SK (2009) Risk of iodinated contrast material-induced nephropathy with intravenous administration. Eur Radiol 19:891–897CrossRefPubMed
35.
Lakhal K, Ehrmann S, Chaari A et al (2011) Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: incidence and outcome. J Crit Care 26:593–599CrossRefPubMed
36.
Garfinkle MA, Stewart S, Basi R (2015) Incidence of CT contrast agent-induced nephropathy: toward a more accurate estimation. AJR Am J Roentgenol 204:1146–1151CrossRefPubMed
37.
Thomas ME, Blaine C, Dawnay A et al (2015) The definition of acute kidney injury and its use in practice. Kidney Int 87:62–73CrossRefPubMed
38.
Fliser D, Laville M, Covic A et al (2012) A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant 27:4263–4272CrossRefPubMedPubMedCentral
39.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470CrossRefPubMed
40.
Levey AS, Coresh J, Greene T et al (2007) Expressing the MDRD study equation for estimating GFR with standardized serum creatinine values. Clin Chem 53:766–772CrossRefPubMed
41.
42.
Levey AS, Stevens LA, Schmid CH, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral
43.
Stevens LA, Li S, Kurella Tamura M et al (2011) Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 57:S9–S16CrossRefPubMedPubMedCentral
44.
Björk J, Jones I, Nyman U, Sjostrom P (2012) Validation of the Lund-Malmo, Chronic Kidney Disease Epidemiology (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) equations to estimate glomerular filtration rate in a large Swedish clinical population. Scand J Urol Nephrol 46:212–222CrossRefPubMed
45.
Schäffner ES, Ebert N, Delanaye P et al (2012) Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med 157:471–481CrossRef
46.
Pottel H, Hoste L, Dubourg L et al (2016) An estimated glomerular filtration rate equation for the full age spectrum. Nephrol Dial Transplant 31:798–806CrossRefPubMedPubMedCentral
47.
Florkowski CM, Chew-Harris JSC (2011) Methods of Estimating GFR – Different Equations Including CKD-EPI. Clin Biochem Rev 32:75–79PubMedPubMedCentral
48.
Delanaye P, Ebert N (2012) Assessment of kidney function: estimating GFR in children. Nat Rev Nephrol 8:503–504CrossRefPubMed
49.
Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263PubMed
50.
51.
Schwartz GJ, Schneider MF, Maier PS et al (2012) Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int 82:445–453CrossRefPubMedPubMedCentral
52.
Martinez Lomakin F, Tobar C (2014) Accuracy of point-of-care serum creatinine devices for detecting patients at risk of contrast-induced nephropathy: a critical overview. Crit Rev Clin Lab Sci 51:332–343CrossRefPubMed
53.
Rao QA, Newhouse JH (2006) Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology 239:392–397CrossRefPubMed
54.
Katzberg RW, Newhouse JH (2010) Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? Radiology 256:21–28CrossRefPubMed
55.
Stratta P, Bozzola C, Quaglia M (2012) Pitfall in nephrology: contrast nephropathy has to be differentiated from renal damage due to atheroembolic disease. J Nephrol 25:282–289CrossRefPubMed
56.
McDonald RJ, McDonald JS, Newhouse JH, Davenport MS (2015) Controversies in contrast material-induced acute kidney injury: closing in on the truth? Radiology 277:627–632CrossRefPubMed
57.
Nyman U, Aspelin P, Jakobsen J, Bjork J (2015) Controversies in contrast material-induced acute kidney injury: Propensity Score matching of patients with different dose/absolute glomerular filtration rate ratios. Radiology 277:633–637CrossRefPubMed
58.
Ricos C, Iglesias N, Garcia-Lario JV et al (2007) Within-subject biological variation in disease: collated data and clinical consequences. Ann Clin Biochem 44:343–352CrossRefPubMed
59.
Wilhelm-Leen E, Montez-Rath ME, Chertow G (2017) Estimating the risk of radiocontrast-associated nephropathy. J Am Soc Nephrol 28:653–659CrossRefPubMed
60.
McDonald JS, McDonald RJ, Comin J et al (2013) Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. Radiology 267:119–128CrossRefPubMed
61.
Schünemann HJ, Tugwell P, Reeves BC et al (2013) Non-randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventions. Res Synth Methods 4:49–62CrossRefPubMed
62.
Davenport MS, Khalatbari S, Dillman JR, Cohan RH, Caoili EM, Ellis JH (2013) Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material. Radiology 267:94–105CrossRefPubMedPubMedCentral
63.
Davenport MS, Khalatbari S, Cohan RH, Dillman JR, Myles JD, Ellis JH (2013) Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. Radiology 268:719–728CrossRefPubMed
64.
McDonald RJ, McDonald JS, Bida JP et al (2013) Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology 267:106–118CrossRefPubMed
65.
McDonald JS, McDonald RJ, Carter RE, Katzberg RW, Kallmes DF, Williamson EE (2014) Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology 271:65–73CrossRefPubMed
66.
McDonald JS, McDonald RJ, Lieske JC et al (2015) Risk of acute kidney injury, dialysis, and mortality in patients with chronic kidney disease after intravenous contrast material exposure. Mayo Clin Proc 90:1046–1053CrossRefPubMedPubMedCentral
67.
Karlsberg RP, Dohad SY, Sheng R (2011) Iodixanol peripheral computed tomographic angiography study investigator panel. Contrast medium acute kidney injury: comparison of intravenous and intra-arterial administration of iodinated contrast medium. J Vasc Intervent Radiol 22:1159–1165CrossRef
68.
Kooiman J, Le Haen PA, Gezgin G et al (2013) Contrast-induced acute kidney injury and clinical outcomes after intra-arterial and intravenous contrast administration: risk comparison adjusted for patient characteristics by design. Am Heart J 165:793–799CrossRefPubMed
69.
McDonald JS, Leake CB, McDonald RJ et al (2016) Acute kidney injury after intravenous versus intra-arterial contrast material administration in a paired cohort. Invest Radiol 51:804–809CrossRefPubMed
70.
Tong GE, Kumar S, Chong KC et al (2016) Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration. Abdom Radiol 41:91–99CrossRef
71.
From AM, Bartholmai BJ, Williams AW, Cha SS, McDonald FS (2008) Mortality associated with nephropathy after radiographic contrast exposure. Mayo Clin Proc 83:1095–1100CrossRefPubMed
72.
Nyman U, Almén T, Jacobsson B, Aspelin P (2012) Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections? Eur Radiol 22:1366–1371CrossRefPubMed
73.
Prasad A, Ortiz-Lopez C, Khan A, Levin D, Kaye DM (2016) Acute kidney injury following peripheral angiography and endovascular therapy: a systematic review of the literature. Catheter Cardiovasc Interv 88:264–273CrossRefPubMed
74.
Aubry P, Brillet G, Catella L, Schmidt A, Bénard S (2016) Outcomes, risk factors and health burden of contrast-induced acute kidney injury: an observational study of one million hospitalizations with image-guided cardiovascular procedures. BMC Nephrol 17:167CrossRefPubMedPubMedCentral
75.
Haider M, Yessayan L, Venkat KK, Goggins M, Patel A, Karthikeyan V (2015) Incidence of contrast-induced nephropathy in kidney transplant recipients. Transplant Proc 47:379–383CrossRefPubMed
76.
Fananapazir G, Troppmann C, Corwin MT, Bent CK, Vu CT, Lamba R (2016) Incidence of contrast-induced nephropathy after renal graft catheter arteriography using iodine-based contrast medium. AJR Am J Roentgenol 206:783–786CrossRefPubMed
77.
Fananapazir G, Troppmann C, Corwin MT, Nikpour AM, Naderi S, Lamba R (2016) Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants. Abdom Radiol 41:2182–2186CrossRef
78.
Haveman JW, Gansevoort RT, Bongaerts AH, Nijsten MW (2006) Low incidence of nephropathy in surgical ICU patients receiving intravenous contrast: a retrospective analysis. Intensive Care Med 32:1199–1205CrossRefPubMed
79.
Hoste EA, Doom S, De Waele J et al (2011) Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis. Intensive Care Med 37:1921–1931CrossRefPubMed
80.
81.
Ehrmann S, Badin J, Savath L et al (2013) Acute kidney injury in the critically ill: is iodinated contrast medium really harmful? Crit Care Med 41:1017–1026CrossRefPubMed
82.
McDonald JS, McDonald RJ, Williamson EE, Kallmes DF, Kashani K (2017) Post-contrast acute kidney injury in intensive care unit patients: a propensity score-adjusted study. Intensive Care Med 43:774–784CrossRefPubMed
83.
Senthilnathan S, Gauvreau K, Marshall AC, Lock JE, Bergersen L (2009) Contrast administration in pediatric cardiac catheterization: dose and adverse events. Catheter Cardiovasc Interv 73:814–820CrossRefPubMed
84.
Huggins N, Nugent A, Modem V et al (2014) Incidence of acute kidney injury following cardiac catheterization prior to cardiopulmonary bypass in children. Catheter Cardiovasc Interv 84:615–619CrossRefPubMed
85.
Cantais A, Hammouda Z, Mory O et al (2016) Incidence of contrast-induced acute kidney injury in a pediatric setting: a cohort study. Pediatr Nephrol 31:1355–1362CrossRefPubMed
86.
Balemans CE, Reichert LJ, van Schelven BI, van den Brand JA, Wetzels JF (2012) Epidemiology of contrast material-induced nephropathy in the era of hydration. Radiology 263:706–713CrossRefPubMed
87.
Kanbay M, Solak Y, Afsar B et al (2017) Serum uric acid and risk for acute kidney injury following contrast: an evaluation of epidemiology, clinical trials, and potential mechanisms. Angiology 68:132–144CrossRefPubMed
88.
Kiski D, Stepper W, Breithardt G, Reinecke H (2010) Impact of female gender on frequency of contrast medium-induced nephropathy: post hoc analysis of dialysis versus diuresis trial. J Womens Health 19:1363–1368CrossRef
89.
90.
Medalion B, Cohen H, Assali A et al (2010) The effect of cardiac angiography timing, contrast media dose, and preoperative renal function on acute renal failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg 139:1539–1544CrossRefPubMed
91.
Ohno Y, Maekawa Y, Miyata H et al (2013) Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention. J Am Coll Cardiol 62:1260–1266CrossRefPubMed
92.
Pannu N, Wiebe N, Tonelli M (2006) Prophylaxis strategies for contrast-induced nephropathy. JAMA 295:2765–2779CrossRefPubMed
93.
Song W, Zhang T, Pu J, Shen L, He B (2014) Incidence and risk of developing contrast-induced acute kidney injury following intravascular contrast administration in elderly patients. Clin Interv Aging 9:85–93PubMed
94.
Toprak O, Cirit M (2006) Risk factors for contrast-induced nephropathy. Kidney Blood Press Res 29:84–93CrossRefPubMed
95.
Yang JQ, Ran P, Chen JY et al (2014) Development of contrast-induced acute kidney injury after elective contrast media exposure in patients with type 2 diabetes mellitus: effect of albuminuria. PLoS One 9:e106454CrossRefPubMedPubMedCentral
96.
Zuo T, Jiang L, Mao S, Liu X, Yin X, Guo L (2016) Hyperuricemia and contrast-induced acute kidney injury: A systematic review and meta-analysis. Int J Cardiol 224:286–294CrossRefPubMed
97.
McDonald JS, McDonald RJ, Williamson EE, Kallmes DF (2017) Is intravenous administration of iodixanol associated with increased risk of acute kidney injury, dialysis, or mortality? a Propensity Score-adjusted study. Radiology. 285: 414-424
98.
Heinrich MC, Häberle L, Müller V, Bautz W, Uder M (2009) Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 250:68–86CrossRefPubMed
99.
From AM, Al Badarin FJ, McDonald FS, Bartholmai BJ, Cha SS, Rihal CS (2010) Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials. Circ Cardiovasc Interv 3:351–358CrossRefPubMed
100.
Eng J, Wilson RF, Subramaniam RM et al (2016) Comparative effect of contrast media type on the incidence of contrast-induced nephropathy: a systematic review and meta-analysis. Ann Intern Med 164:417–424CrossRefPubMed
101.
Barrett BJ, Carlisle EJ (1993) Meta-analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188:171–178CrossRefPubMed
102.
Gurm HS, Dixon SR, Smith DE, BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) Registry et al (2011) Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 58:907–914CrossRefPubMed
103.
Kooiman J, Seth M, Share D, Dixon S, Gurm HS (2014) The association between contrast dose and renal complications post-PCI across the continuum of procedural estimated risk. PLoS One 9:e90233CrossRefPubMedPubMedCentral
104.
Nyman U, Björk J, Aspelin P, Marenzi G (2008) Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention. Acta Radiol 49:658–667CrossRefPubMed
105.
Nyman U (2016) Contrast dose, estimated GFR and techniques to reduce contrast dose in PCI – time to consider some basic principles! J Invas Cardiol 28:E126–E127
Metadata
Title
Post-contrast acute kidney injury – Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors
Recommendations for updated ESUR Contrast Medium Safety Committee guidelines
Authors
Aart J. van der Molen
Peter Reimer
Ilona A. Dekkers
Georg Bongartz
Marie-France Bellin
Michele Bertolotto
Olivier Clement
Gertraud Heinz-Peer
Fulvio Stacul
Judith A. W. Webb
Henrik S. Thomsen
Publication date
01-07-2018
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 7/2018
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-017-5246-5

Other articles of this Issue 7/2018

European Radiology 7/2018 Go to the issue

Magnetic Resonance

Utility of MRI for cervical spine clearance in blunt trauma patients after a negative CT

Musculoskeletal

Detection of early cartilage damage: feasibility and potential of gagCEST imaging at 7T

Musculoskeletal

Editorial comment: the future of compositional MRI for cartilage

Musculoskeletal

Early percutaneous vertebroplasty helps motorsport professionals to resume competition soon after vertebral fracture

Oncology

Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer

Interventional

Endovascular interventional modalities for haemorrhage control in abnormal placental implantation deliveries: a systematic review and meta-analysis